Home >
Medicine Info >
NovoMix 30 Penfill Injection
Loading interface...

NovoMix 30 Penfill Injection

Manufactured byNOVO NORDISK INDIA PVT LTD
ContainsInsulin Aspart (30 International units ) + Insulin Aspart Protamine (70 International units )
Description
NovoMix 30 Penfill Injection is used for the treatment of diabetes mellitus (a condition with high blood sugar levels). This medicine is a combination of rapid-acting and intermediate-acting types of insulin that provide effective blood sugar control throughout the day. NovoMix 30 Penfill Injection may result in low blood sugar levels, and you may feel hungry, irritable, dizzy, anxious, or shaky. Consult your doctor if these symptoms persist or become severe. Avoid consumption of alcohol during treatment with this medicine, as it may lower your blood sugar levels. This medicine may also cause low blood potassium levels, weight gain, swelling of your hands and feet, redness/swelling/itching at the site of the injection, etc. NovoMix 30 Penfill Injection should be administered exactly as advised by your doctor. This medicine is to be injected under the skin. Administer it at the same time every day to maintain a constant level of this medicine in your body. Do not skip doses or discontinue the treatment without consulting your doctor, as it may cause an increase in your blood sugar levels. NovoMix 30 Penfill Injection is not recommended if you are allergic to it. Inform your doctor if you have pre-existing liver or kidney problems. If you are pregnant or are breastfeeding, consult your doctor before starting treatment with this medicine.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Side effects

Major & minor side effects for NovoMix 30 Penfill Injection

  • Decreased blood glucose levels
  • Headache
  • Pain at injection site
  • Dizziness
  • Tingling of hands, feet, lips or tongue
  • Confusion
  • Weight gain

Uses of NovoMix 30 Penfill Injection

What is it prescribed for?

  • Type I Diabetes mellitus
  • Type II Diabetes Mellitus
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    NovoMix 30 Penfill Injection begins to show its effect within 10-20 minutes after administration.
  • How long do the effects of this medicine last?
    The effect of NovoMix 30 Penfill Injection lasts for an approximate duration of 24 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with NovoMix 30 Penfill Injection as it may alter your blood sugar levels.
  • Is this a habit forming medicine?
    No habit-forming tendencies have been reported with NovoMix 30 Penfill Injection.
  • Can this medicine be taken during pregnancy?
    NovoMix 30 Penfill Injection is not known to affect your developing foetus when taken during pregnancy. Hence this medicine may be safe to use during pregnancy upon your doctor's recommendation.
  • Can this medicine be taken while breast-feeding?
    NovoMix 30 Penfill Injection may be safe for use during breastfeeding upon your doctor's recommendation.

Allergy

NovoMix 30 Penfill Injection is not recommended for use if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of your face/tongue/throat), severe dizziness, breathing difficulty, etc.
Warnings for special population

Pregnancy

NovoMix 30 Penfill Injection is not known to affect your developing foetus when taken during pregnancy. Hence this medicine may be safe to use during pregnancy upon your doctor's recommendation.

Breast-feeding

NovoMix 30 Penfill Injection may be safe for use during breastfeeding upon your doctor's recommendation.
General warnings

Hypoglycaemia

NovoMix 30 Penfill Injection may cause low blood sugar levels. Hence, regular monitoring of your blood sugar levels is recommended. Your doctor may advise you to carry a sugar candy to counteract the effects of low blood sugar levels.

Driving and operating machines

Your ability to drive vehicles or operate machines may be affected due to low or high blood sugar levels. Hence, avoid activities that require mental alertness if you experience symptoms such as dizziness, blurred vision, etc., during treatment with NovoMix 30 Penfill Injection.

Changing the type and brand of insulin

NovoMix 30 Penfill Injection should not be diluted or mixed with any other insulin or solution, as it may alter the effects of other insulins when administered together and/or increase the risk of side effects.

Single Person Use

Never share NovoMix 30 Penfill Injection with others, as it may lead to the transfer of infection or disease from one person to another.

Allergic Reactions at the injection Site

Injection site reactions that may occur with NovoMix 30 Penfill Injection include redness, pain, itching, swelling or hives (itchy, painful eruptions that sting). Continuous rotation of the injection site within a given area is recommended to help reduce or prevent these reactions. These reactions usually resolve within a few days to a few weeks.

Use in Children

NovoMix 30 Penfill Injection is not recommended for use in children below 18 years of age as the safety and efficacy of use are not clinically established.

Subcutaneous use only

NovoMix 30 Penfill Injection is meant for subcutaneous administration (under the skin) only. The long duration of action of this medicine is dependent on a subcutaneous administration. It should not be administered intravenously (into the veins) or intramuscularly (into the muscles).

Missed Dose

If you miss a dose of NovoMix 30 Penfill Injection, contact your doctor for further instructions. You should not use more than one dose in 24 hours unless specifically instructed by your doctor.

Overdose

Seek immediate medical attention if an overdose of NovoMix 30 Penfill Injection is suspected. Hypoglycaemia (low blood sugar levels) may occur in case of an overdose with symptoms such as extreme weakness, blurred vision, sweating, trouble speaking, tremors, dizziness, confusion, etc. In cases of mild hypoglycemic episodes, oral glucose or sugary products can be used to avoid severe hypoglycaemia.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with NovoMix 30 Penfill Injection as it may alter your blood sugar levels.
Interaction with Medicine

Prednisolone

Aspirin

Ramipril

Atenolol

Ciprofloxacin

Disease interactions

Kidney/liver disease

NovoMix 30 Penfill Injection should be used with caution if you have pre-existing kidney/liver problems due to the increased risk of side effects. Your doctor may recommend dose adjustments based on your clinical condition.

Hypokalaemia

NovoMix 30 Penfill Injection should be used with caution as it may increase the risk of hypokalaemia (low blood potassium levels). Your doctor may suggest tests to monitor your blood potassium levels periodically while on treatment with this medicine.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Carefully follow all the instructions given by your doctor. Do not administer NovoMix 30 Penfill Injection in larger or smaller amounts than prescribed. Administer NovoMix 30 Penfill Injection 15 minutes before your meal. However, for type 2 diabetes, the dose may also be taken after the meal. Never share an injection pen, cartridge, or syringe with another person, even if the needle has been changed. Avoid the use of NovoMix 30 Penfill Injection if the solution is cloudy, coloured, or contains solid particles. Avoid the discontinuation of this medicine without consulting your doctor, as it may increase your blood sugar levels. Regular monitoring of blood sugar levels and frequent follow-up visits with your doctor is recommended so that your doctor can evaluate your condition.
Miscelleneous

To be taken before food

To be taken as instructed by doctor

Does not cause sleepiness

How it works
NovoMix 30 Penfill Injection is a modified form of insulin that works similarly to human insulin (a hormone created by your pancreas that helps regulate blood sugar levels). It improves blood sugar control by enhancing sugar uptake from the blood into body tissues and also by preventing the production of sugar in the liver.
Legal Status

Unknown

Approved

Unknown

Approved

Classification

Category

Insulin, Insulin analog combination, Antidiabetic agents

Schedule

Schedule H

Dailymed.nlm.nih.gov. 2022. DailyMed - NOVOLOG MIX 70/30- insulin aspart injection, suspension. [online] Available at: [Accessed 28 June 2022].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1861fcee-7673-4afe-a206-08fa05c0add2

Accessdata.fda.gov. 2022. [online] Available at: [Accessed 28 June 2022].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021172s034lbl.pdf

70/30, N., 2022. About NovoLog® Mix 70/30 | NovoLog® Mix 70/30 (insulin aspart protamine and insulin aspart injectable suspension) 100 U/mL. [online] Novologmix70-30.com. Available at: [Accessed 28 June 2022].

https://www.novologmix70-30.com/

Ebs.tga.gov.au. 2022. TGA eBS - Product and Consumer Medicine Information Licence. [online] Available at: [Accessed 28 June 2022].

https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-02966-3&d=20220628172310101
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 5 Jul 2022

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.